Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008816HBVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS10008817HBVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30015544HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30015545HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30012392HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30002813HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30015546HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30007221HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30018369HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TVIS30075555HIVENSG00000161533.12protein_codingACOX1NoNo51Q15067
TCGA Plot Options
Drug Information
GeneACOX1
DrugBank IDDB03147
Drug NameFlavin adenine dinucleotide
Target IDBE0004135
UniProt IDQ15067
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved
Direct ClassificationFlavin nucleotides
SMILESCC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC3=C1N=CN=C3N)C1=NC(=O)NC(=O)C1=N2
PathwaysCerivastatin Action Pathway; Ethylmalonic Encephalopathy; 3-Methylglutaconic Aciduria Type III; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Caffeine Metabolism; Isovaleric Aciduria; Lysine Degradation; Riboflavin Metabolism; 5-Oxoprolinuria; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Glycerol Phosphate Shuttle; Propionic Acidemia; Hypercholesterolemia; Xanthine Dehydrogenase Deficiency (Xanthinuria); S-Adenosylhomocysteine (SAH) Hydrolase Deficiency; Tryptophan Metabolism; Glutaric Aciduria Type I; 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Phenylketonuria; Glycine N-Methyltransferase Deficiency; Dimethylglycine Dehydrogenase Deficiency; Lovastatin Action Pathway; 3-Methylglutaconic Aciduria Type IV; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Glutathione Metabolism; Folate Metabolism; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease; Glycerol Kinase Deficiency; Adenylosuccinate Lyase Deficiency
PharmGKB
ChEMBLCHEMBL1232653